ArticleFrontiers in neurology2025
Assessment of a novel patient reported outcome measure for visual snow syndrome: the Colorado visual snow survey 2.0.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Visual snow syndrome (VSS) is a condition in which people experience a continuous overlay of small dots atop their entire visual field. As a newly recognized condition, there is a gap in patient reported outcome measures (PROMs) that target VSS symptom impact. Methods: We sought to assess the Colorado Visual Snow Survey 2.0 (CVSS) as a possible PROM for VSS using a convenience sample of undergraduate students and people with VSS recruited through the Visual Snow Initiative (N = 144). Results: We found the CVSS (1) strongly differentiated people with VSS from healthy controls, (2) demonstrated high internal consistency, and (3) aside from visual static, the degree of night vision impairment, blue field entoptic phenomenon, and afterimages, and tinnitus (in that order) best predicted group membership. We also find evidence to suggest people with VSS may be more sensitive to entoptic phenomenon and depersonalization/derealization than control participants. Conclusion: Overall, CVSS is a promising PROM that warrants further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.